Serum CTX testing.
作者信息
Schwartz Harry C
出版信息
J Oral Maxillofac Surg. 2008 Jun;66(6):1319-20; author reply 1320. doi: 10.1016/j.joms.2007.12.048.
PMID:18486810
Abstract
摘要
相似文献
1
Serum CTX testing.
J Oral Maxillofac Surg. 2008 Jun;66(6):1319-20; author reply 1320. doi: 10.1016/j.joms.2007.12.048.
2
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
J Oral Maxillofac Surg. 2008 Jun;66(6):1320-1; author reply 1321-2. doi: 10.1016/j.joms.2008.01.054.
3
Osteonecrosis of the jaw and biomarkers: what do we tell our patients?
Int J Oral Maxillofac Implants. 2008 Mar-Apr;23(2):179-80.
4
Editorial opinion versus real data and knowledge of the literature.
Int J Oral Maxillofac Implants. 2008 Jul-Aug;23(4):587-8.
5
CTX and its role in managing patients exposed to oral bisphosphonates.
J Oral Maxillofac Surg. 2010 Feb;68(2):487-8; author reply 488-9. doi: 10.1016/j.joms.2009.07.088. Epub 2010 Jan 15.
6
CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part I: biological concepts with a review of the literature.
Implant Dent. 2009 Dec;18(6):492-500. doi: 10.1097/ID.0b013e3181c6837c.
7
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410. doi: 10.1016/j.joms.2007.08.003.
8
Bisphosphonates--what the dentist needs to know: practical considerations.
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):53-60. doi: 10.1016/j.joms.2009.01.011.
9
Bisphosphonate-induced osteonecrosis: dental considerations.
Compend Contin Educ Dent. 2008 Mar;29(2):112-3.
10
Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
J Oral Maxillofac Surg. 2010 Sep;68(9):2241-7. doi: 10.1016/j.joms.2010.05.043.
引用本文的文献
1
Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.
J Oral Maxillofac Surg. 2016 Apr;74(4):738-46. doi: 10.1016/j.joms.2015.09.028. Epub 2015 Oct 3.
Zotero 插件